FDA Posts Investigator In Singapore, But Trims Foreign Office List
This article was originally published in The Tan Sheet
Executive Summary
FDA's Office of International Programs consolidates its China offices to "strategically focus its resources." FDA shifts away from primarily a domestic focus to global as drug criminal organizations spread globally
You may also be interested in...
FDA Mutual Reliance With EU On Inspections Is Slow Going
FDA still does over 40% of its inspections in Europe even as it acknowledges it must spend the money elsewhere.
FDA’s New Criminal Investigations Chief Wants Global Reach
Office of Criminal Investigations Director George Karavetsos talks about the Park Doctrine and off-label enforcement in interview with “The Pink Sheet.”
FDA Field Operations Would Endure Reductions Under Budget
President Obama’s FY 2016 blueprint includes cuts to ‘low-priority’ enforcement, surveillance and other activities in FDA human drugs and biologics programs, but still increases those operations overall.